Daniel R. Passeri, CHIEF EXECUTIVE OFFICER at Cue Biopharma, Inc. (CUE), bought 3,000 shares at $2.86 ($9K) on 2023-08-14, disclosed to the SEC on 2023-08-16.
Open-market purchase of $9k CUE by CHIEF EXECUTIVE OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CUE | BUY | 2019-06-25 | $10K | — | Filing → |
| CUE | BUY | 2019-06-07 | $21K | — | Filing → |
| CUE | BUY | 2018-08-20 | $49K | — | Filing → |